Gonabreed Recall

Get an alert when a recall is issued.

Add Recall Info

Comment

Cancel Post Info

Questions & Answers

Ask a Question/Reply

Message

Cancel Post Message

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Add Side Effects & Adverse Reactions Info

Comment

Cancel Post Info

Legal Issues

There is currently no legal information available for this drug.

Add Legal Issue Info

Comment

Cancel Post Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add FDA Safety Alert Info

Comment

Cancel Post Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Manufacturer Warning Info

Comment

Cancel Post Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add FDA Labeling Change Info

Comment

Cancel Post Info

Uses

INDICATIONS AND DOSAGE:

Cystic Ovaries

GONAbreed is indicated for the treatment of ovarian follicular cysts in dairy cattle. Ovarian cysts are non-ovulated follicles with incomplete luteinization which result in nymphomania or irregular estrus.

Historically, cystic ovaries have responded to an exogenous source of luteinizing hormone (LH) such as human chorionic gonadotrophin. GONAbreed initiates release of endogenous LH to cause ovulation and luteinization.

The recommended intravenous or intramuscular dosage of GONAbreed is 100 mcg (1 mL) per cow.

Reproductive Synchrony

GONAbreed is indicated for use with cloprostenol sodium to synchronize estrous cycles to allow for fixed time artificial insemination (FTAI) in lactating dairy cows and beef cows.

The recommended intramuscular dosage of GONAbreed is 100 mcg (1 mL) per cow, used in reproductive synchrony programs similar to the following:

• Administer the first GONAbreed injection (1 mL) at Time 0.
• Administer 500 mcg cloprostenol (as cloprostenol sodium) by intramuscular injection 6 to 8 days after the first GONAbreed injection.
• Administer the second GONAbreed injection (1 mL) 30 to 72 hours after the cloprostenol sodium injection.
• Perform FTAI 0 to 24 hours after the second GONAbreed injection, or inseminate cows on detected estrus using standard herd practices.

Add Uses Info

Comment

Cancel Post Info

History

There is currently no drug history available for this drug.

Add History Info

Comment

Cancel Post Info

Other Information

DESCRIPTION:

GONAbreed is a sterile solution containing 100 micrograms of gonadorelin (GnRH) as gonadorelin acetate per milliliter suitable for intramuscular or intravenous administration according to the indication. Gonadorelin is a decapeptide composed of the sequence of amino acids –

5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 –

a molecular weight of 1182.32 and empirical formula C55H75N17O13. The acetate salt has a molecular weight of 60.05 and an empirical formula C55H75N17O13. C2H4O2.

Gonadorelin is the hypothalamic releasing factor responsible for the release of gonadotropins (e.g., LH, FSH) from the anterior pituitary. Synthetic gonadorelin is physiologically and chemically identical to the endogenous bovine hypothalamic releasing factor.

Add Other Info

Comment

Cancel Post Info

Sources